{"id":115736,"date":"2014-03-12T09:47:24","date_gmt":"2014-03-12T13:47:24","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/examining-potential-of-clinical-applications-of-whole-genome-sequencing.php"},"modified":"2014-03-12T09:47:24","modified_gmt":"2014-03-12T13:47:24","slug":"examining-potential-of-clinical-applications-of-whole-genome-sequencing","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/examining-potential-of-clinical-applications-of-whole-genome-sequencing.php","title":{"rendered":"Examining potential of clinical applications of whole-genome sequencing"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    11-Mar-2014  <\/p>\n<p>    Contact: Krista Conger    <a href=\"mailto:kristac@stanford.edu\">kristac@stanford.edu<\/a>    650-725-5271    The JAMA Network    Journals<\/p>\n<p>    In an exploratory study involving 12 adults, the use of    whole-genome sequencing (WGS) was associated with incomplete    coverage of inherited-disease genes, low reproducibility of    detection of genetic variation with the highest potential    clinical effects, and uncertainty about clinically reportable    findings, although in certain cases WGS will identify genetic    variants warranting early medical intervention, according to a    study in the March 12 issue of JAMA.  <\/p>\n<p>    As technical barriers to human DNA sequencing decrease and    costs approach $1,000, whole-genome sequencing (WGS) is    increasingly being used in clinical medicine. Sequencing can    successfully aid clinical diagnosis and reveal the genetic    basis of rare familial diseases. Regardless of context, even in    apparently healthy individuals, WGS is expected to uncover    genetic findings of potential clinical importance. However,    comprehensive clinical interpretation and reporting of    clinically significant findings are seldom performed, according    to background information in the article. The technical    sensitivity and reproducibility of clinical genetic findings    using sequencing and the clinical opportunities and costs    associated with discovery and reporting of these and other    clinical findings remain undefined.  <\/p>\n<p>    Frederick E. Dewey, M.D., of the Stanford Center for Inherited    Cardiovascular Disease, Stanford, Calif., and colleagues    recruited 12 volunteer adult participants who underwent WGS    between November 2011 and March 2012. A multidisciplinary team    reviewed all potentially reportable genetic findings. Five    physicians proposed initial clinical follow-up based on the    genetic findings.  <\/p>\n<p>    The researchers found that the use of WGS was associated with    incomplete coverage of inherited-disease genes (important parts    of the genome for diseases that run in families are not as easy    to read as other regions); there was low reproducibility of    detection of genetic variation with the highest potential    clinical effects (disagreement around the types of variation    particularly important for disease); and there was uncertainty    about clinically reportable WGS findings (experts disagree on    which findings are most meaningful). Two to 6 personal    disease-risk findings were discovered in each participant.    Physician review of sequencing findings prompted consideration    of a median (midpoint) of 1 to 3 initial diagnostic tests and    referrals per participant.  <\/p>\n<p>    The authors write that their clinical experience with this    technology illustrates several challenges to clinical adoption    of WGS, including that although analytical validity of WGS is    improving, technical challenges to sensitive and accurate    assessment of individual genetic variation remain. In addition,    the human resource needs for full clinical interpretation of    WGS data remains considerable, and much uncertainty remains in    classification of potentially disease-causing genetic variants.  <\/p>\n<p>    \"These issues should be considered when determining the role of    WGS in clinical medicine.\"  <\/p>\n<p>    ###  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the original post:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-03\/tjnj-epo030614.php\/RK=0\/RS=ta4v.BQohzTvu3QDM6rsXysKjKY-\" title=\"Examining potential of clinical applications of whole-genome sequencing\">Examining potential of clinical applications of whole-genome sequencing<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 11-Mar-2014 Contact: Krista Conger <a href=\"mailto:kristac@stanford.edu\">kristac@stanford.edu<\/a> 650-725-5271 The JAMA Network Journals In an exploratory study involving 12 adults, the use of whole-genome sequencing (WGS) was associated with incomplete coverage of inherited-disease genes, low reproducibility of detection of genetic variation with the highest potential clinical effects, and uncertainty about clinically reportable findings, although in certain cases WGS will identify genetic variants warranting early medical intervention, according to a study in the March 12 issue of JAMA. As technical barriers to human DNA sequencing decrease and costs approach $1,000, whole-genome sequencing (WGS) is increasingly being used in clinical medicine.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/examining-potential-of-clinical-applications-of-whole-genome-sequencing.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-115736","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/115736"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=115736"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/115736\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=115736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=115736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=115736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}